
|Articles|June 1, 2004
Resiniferatoxin 'mildly successful' in idiopathic OAB
Vanilloid is shown to improve urgency but not pain, leakage, nocturia, or enuresis
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Laura Bukavina, MD, and Gabriela Díaz, MD, on the rise of young-onset bladder cancer
3
Individualizing androgen pathway therapy in mCSPC
4
BOND-003 Cohort C: Efficacy Results
5








